In January 2010 the FDA announced it found an increased risk of heart attack and stroke in patients with a history of cardiovascular disease who used the weight loss medication Meridia (sibutramine), based on the agency’s review of additional safety data from a large study. Given the serious nature of these recent findings, the FDA requested and Abbott Laboratories agreed to add a new warning to the package insert, or label, for Meridia.The new Meridia label will include a warning which states that Meridia is not to be used in patients with a history of cardiovascular disease, such as a history of heart attack, stroke, heart arrhythmias, congestive heart failure and uncontrolled hypertension.

At the same time, the FDA said that later this year it will convene an open public advisory committee meeting to discuss Meridia’s safety. The investigation with look at the drug benefits vs. side effect risks, to determine if additional regulatory actions should be taken by the FDA as regards Meridia.

A number of lawsuits have been filed, alleging that the limited weight-loss benefits provided by Meridia are outweighed by the increased risk of cardiovascular problems. The attorneys represent people who took Meridia and had a heart attack or stroke while on Meridia.

If you or a loved one were on Meridia and suffered a heart attack or stroke you may have a significant claim against the manufacturer of Meridia. To protect your rights, contact the Solberg, Stewart & Miller law firm. All initial Meridia consultations are free. If the firm takes your Meridia case you pay no attorney fees or expenses, unless and until you make a recovery for your injuries. Contact attorney Mike Miller at mmiller@solberglaw.com or call him at 237-3166 (Fargo) or 1.877-237-3166 (toll free).